Efficacy and Safety of the APGO Algorithm for Automated Insulin Delivery
Recruiting
N/A
Interventional Study
Diabetes Mellitus Type 1
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 200 (estimated)
- Sponsor
- Charles University, Czech Republic · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The Medtrum TouchCare Nano system with the APGO algorithm is the only patch pump-based automated insulin delivery system available in the Czech Republic. However, until now, no prospective clinical study has evaluated its efficacy and safety under real-world conditions. The RENEW study is the first to address this topic.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* patients with T1D
* type 1 diabetes for ≥1 years
* ≥ 18 years old
* written informed consent prior to starting study related activity
Exclusion Criteria:
* severe noncompliance
* lactation, pregnancy, intending to become pregnant during study
* use of medication with effects…
Contacts